We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Parallel import licences granted in 2025.
How to get a parallel import licence for your medicine in the UK, including pharmacovigilance requirements and submitting your application.
Actions that intellectual property rights holders and parallel exporters and to and from the European Economic Area (EEA) need to take.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
Parallel import (PLPI) licences granted since January 2014.
Sets out medicines that cannot be exported from the UK or hoarded because they are needed for UK patients.
Guidance for the pharmaceutical industry on how to apply for an authorisation to place a veterinary medicine on the UK market or part of, or to expire one.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).